Literature DB >> 23914967

Computational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy.

Chanchala D Kaddi1, John H Phan, May D Wang.   

Abstract

Nanoparticle-mediated hyperthermia for cancer therapy is a growing area of cancer nanomedicine because of the potential for localized and targeted destruction of cancer cells. Localized hyperthermal effects are dependent on many factors, including nanoparticle size and shape, excitation wavelength and power, and tissue properties. Computational modeling is an important tool for investigating and optimizing these parameters. In this review, we focus on computational modeling of magnetic and gold nanoparticle-mediated hyperthermia, followed by a discussion of new opportunities and challenges.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23914967      PMCID： PMC4983427          DOI： 10.2217/nnm.13.117

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


  58 in total

Review 1.  A metabolic network approach for the identification and prioritization of antimicrobial drug targets.

Authors:  Arvind K Chavali; Kevin M D'Auria; Erik L Hewlett; Richard D Pearson; Jason A Papin
Journal:  Trends Microbiol       Date:  2012-01-31       Impact factor: 17.079

2.  Numerical investigation of heating of a gold nanoparticle and the surrounding microenvironment by nanosecond laser pulses for nanomedicine applications.

Authors:  E Sassaroli; K C P Li; B E O'Neill
Journal:  Phys Med Biol       Date:  2009-08-28       Impact factor: 3.609

Review 3.  Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.

Authors:  Sophie Laurent; Silvio Dutz; Urs O Häfeli; Morteza Mahmoudi
Journal:  Adv Colloid Interface Sci       Date:  2011-04-30       Impact factor: 12.984

Review 4.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action.

Authors:  Shan Zhao; Ravi Iyengar
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012       Impact factor: 13.820

5.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.

Authors:  Manfred Johannsen; Uwe Gneveckow; Burghard Thiesen; Kasra Taymoorian; Chie Hee Cho; Norbert Waldöfner; Regina Scholz; Andreas Jordan; Stefan A Loening; Peter Wust
Journal:  Eur Urol       Date:  2006-11-17       Impact factor: 20.096

Review 6.  Targeted hyperthermia using metal nanoparticles.

Authors:  Paul Cherukuri; Evan S Glazer; Steven A Curley
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 7.  Heating the patient: a promising approach?

Authors:  J van der Zee
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.

Authors:  Georgios S Stamatakos; Eleni C Georgiadi; Norbert Graf; Eleni A Kolokotroni; Dimitra D Dionysiou
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

10.  A comparison of methods for differential expression analysis of RNA-seq data.

Authors:  Charlotte Soneson; Mauro Delorenzi
Journal:  BMC Bioinformatics       Date:  2013-03-09       Impact factor: 3.169
View more
  13 in total

1.  Hybrid Modeling of Ebola Propagation.

Authors:  Cyrus Tanade; Nathanael Pate; Elianna Paljug; Ryan A Hoffman; May D Wang
Journal:  Proc IEEE Int Symp Bioinformatics Bioeng       Date:  2019-12-26

2.  Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.

Authors:  Hunter A Miller; Hermann B Frieboes
Journal:  Pharm Res       Date:  2019-11-26       Impact factor: 4.200

3.  Evaluation of uptake and distribution of gold nanoparticles in solid tumors.

Authors:  Christopher G England; André M Gobin; Hermann B Frieboes
Journal:  Eur Phys J Plus       Date:  2015-11-19       Impact factor: 3.911

4.  Nanoparticle transport phenomena in confined flows.

Authors:  Ravi Radhakrishnan; Samaneh Farokhirad; David M Eckmann; Portonovo S Ayyaswamy
Journal:  Adv Heat Transf       Date:  2019-10-04

Review 5.  Nanotechnology and artificial intelligence to enable sustainable and precision agriculture.

Authors:  Peng Zhang; Zhiling Guo; Sami Ullah; Georgia Melagraki; Antreas Afantitis; Iseult Lynch
Journal:  Nat Plants       Date:  2021-06-24       Impact factor: 15.793

6.  An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.

Authors:  Louis T Curtis; Christopher G England; Min Wu; John Lowengrub; Hermann B Frieboes
Journal:  Nanomedicine (Lond)       Date:  2016-02       Impact factor: 5.307

Review 7.  Sex as an important factor in nanomedicine.

Authors:  Mohammah Javad Hajipour; Haniyeh Aghaverdi; Vahid Serpooshan; Hojatollah Vali; Sara Sheibani; Morteza Mahmoudi
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

8.  In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles.

Authors:  Giovanni Baldi; Costanza Ravagli; Filippo Mazzantini; George Loudos; Jaume Adan; Marc Masa; Dimitrios Psimadas; Eirini A Fragogeorgi; Erica Locatelli; Claudia Innocenti; Claudio Sangregorio; Mauro Comes Franchini
Journal:  Int J Nanomedicine       Date:  2014-06-24

9.  Simulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor.

Authors:  Hermann B Frieboes; Louis T Curtis; Min Wu; Kian Kani; Parag Mallick
Journal:  Cancer Inform       Date:  2015-12-20

10.  Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles.

Authors:  Louis T Curtis; Min Wu; John Lowengrub; Paolo Decuzzi; Hermann B Frieboes
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.